Software - Application
Build Your Comparison
Side-by-side financial analysisStock Comparison
PTRN vs PRCH vs HIFS vs LMND
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
Banks - Regional
Insurance - Property & Casualty
PTRN vs PRCH vs HIFS vs LMND — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Software - Application | Software - Application | Banks - Regional | Insurance - Property & Casualty |
| Market Cap | $2.97B | $1.25B | $635M | $4.67B |
| Revenue (TTM) | $2.73B | $483M | $237M | $821M |
| Net Income (TTM) | $-141M | $-9M | $55M | $-139M |
| Gross Margin | 43.2% | 72.4% | 43.6% | 47.6% |
| Operating Margin | 1.3% | 10.3% | 30.7% | -16.3% |
| Forward P/E | 34.7x | — | 20.5x | — |
| Total Debt | $31M | $393M | $1.46B | $182M |
| Cash & Equiv. | $289M | $53M | $7M | $385M |
PTRN vs PRCH vs HIFS vs LMND — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 20 | Jun 26 | Return |
|---|---|---|---|
| Porch Group, Inc. (PRCH) | 100 | 111.1 | +11.1% |
| Hingham Institution… (HIFS) | 100 | 163.5 | +63.5% |
| Lemonade, Inc. (LMND) | 100 | 104.4 | +4.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PTRN vs PRCH vs HIFS vs LMND
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PTRN is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 1.65, Low D/E 5.3%, current ratio 2.34x
- Beta 1.65, current ratio 2.34x
PRCH is the clearest fit if your priority is income & stability.
- Dividend streak 1 yrs, beta 2.15
HIFS carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 151.6% 10Y total return vs PTRN's 22.6%
- Better valuation composite
- 23.0% margin vs LMND's -16.9%
- Beta 1.20 vs LMND's 2.50
LMND is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 40.2%, EPS growth 19.3%, 3Y rev CAGR 42.2%
- 40.2% revenue growth vs HIFS's 8.9%
- +44.7% vs PRCH's +1.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 40.2% revenue growth vs HIFS's 8.9% | |
| Value | Better valuation composite | |
| Quality / Margins | 23.0% margin vs LMND's -16.9% | |
| Stability / Safety | Beta 1.20 vs LMND's 2.50 | |
| Dividends | 0.9% yield; 1-year raise streak; the other 3 pay no meaningful dividend | |
| Momentum (1Y) | +44.7% vs PRCH's +1.3% | |
| Efficiency (ROA) | 1.2% ROA vs PTRN's -16.3%, ROIC 2.8% vs 6.8% |
PTRN vs PRCH vs HIFS vs LMND — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
PTRN vs PRCH vs HIFS vs LMND — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HIFS leads in 2 of 6 categories
PRCH leads 1 • PTRN leads 0 • LMND leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
HIFS leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PTRN is the larger business by revenue, generating $2.7B annually — 11.6x HIFS's $237M. HIFS is the more profitable business, keeping 23.0% of every revenue dollar as net income compared to LMND's -16.9%. On growth, LMND holds the edge at +55.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $2.7B | $483M | $237M | $821M |
| EBITDAEarnings before interest/tax | $54M | $72M | $73M | -$121M |
| Net IncomeAfter-tax profit | -$141M | -$9M | $55M | -$139M |
| Free Cash FlowCash after capex | $99M | $72M | $36M | $20M |
| Gross MarginGross profit ÷ Revenue | +43.2% | +72.4% | +43.6% | +47.6% |
| Operating MarginEBIT ÷ Revenue | +1.3% | +10.3% | +30.7% | -16.3% |
| Net MarginNet income ÷ Revenue | -5.2% | -1.8% | +23.0% | -16.9% |
| FCF MarginFCF ÷ Revenue | +3.6% | +15.0% | +15.0% | +2.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +43.2% | +15.6% | — | +55.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +80.0% | -157.1% | +195.1% | +45.3% |
Valuation Metrics
HIFS leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, PRCH's 27.7x EV/EBITDA is more attractive than PTRN's 64.3x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $3.0B | $1.2B | $635M | $4.7B |
| Enterprise ValueMkt cap + debt − cash | $2.7B | $1.6B | $2.1B | $4.5B |
| Trailing P/EPrice ÷ TTM EPS | -21.54x | -351.85x | 11.62x | -26.41x |
| Forward P/EPrice ÷ next-FY EPS est. | 34.70x | — | 20.49x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | 9.24x | — |
| EV / EBITDAEnterprise value multiple | 64.31x | 27.75x | 28.53x | — |
| Price / SalesMarket cap ÷ Revenue | 1.19x | 2.59x | 2.68x | 6.32x |
| Price / BookPrice ÷ Book value/share | 5.82x | 52.80x | 1.32x | 8.18x |
| Price / FCFMarket cap ÷ FCF | 37.66x | 23.96x | 17.87x | — |
Profitability & Efficiency
PRCH leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
HIFS delivers a 12.0% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-61 for PRCH. PTRN carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to PRCH's 17.55x. On the Piotroski fundamental quality scale (0–9), PRCH scores 8/9 vs LMND's 4/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -26.2% | -60.9% | +12.0% | -26.5% |
| ROA (TTM)Return on assets | -16.3% | -1.1% | +1.2% | -7.4% |
| ROICReturn on invested capital | +6.8% | +9.9% | +2.8% | -36.8% |
| ROCEReturn on capital employed | +5.0% | +6.5% | +2.8% | -22.7% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 8 | 6 | 4 |
| Debt / EquityFinancial leverage | 0.05x | 17.55x | 3.05x | 0.34x |
| Net DebtTotal debt minus cash | -$258M | $340M | $1.5B | -$203M |
| Cash & Equiv.Liquid assets | $289M | $53M | $7M | $385M |
| Total DebtShort + long-term debt | $31M | $393M | $1.5B | $182M |
| Interest CoverageEBIT ÷ Interest expense | — | 1.35x | 0.55x | — |
Total Returns (Dividends Reinvested)
Evenly matched — PTRN and PRCH each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PTRN five years ago would be worth $12,265 today (with dividends reinvested), compared to $6,302 for PRCH. Over the past 12 months, LMND leads with a +44.7% total return vs PRCH's +1.3%. The 3-year compound annual growth rate (CAGR) favors PRCH at 100.2% vs PTRN's 7.0% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +66.7% | +23.6% | +6.6% | -20.0% |
| 1-Year ReturnPast 12 months | +22.6% | +1.3% | +26.9% | +44.7% |
| 3-Year ReturnCumulative with dividends | +22.6% | +702.8% | +37.1% | +208.3% |
| 5-Year ReturnCumulative with dividends | +22.6% | -37.0% | +3.4% | -36.5% |
| 10-Year ReturnCumulative with dividends | +22.6% | +15.2% | +151.6% | -12.5% |
| CAGR (3Y)Annualised 3-year return | +7.0% | +100.2% | +11.1% | +45.5% |
Risk & Volatility
Evenly matched — PTRN and HIFS each lead in 1 of 2 comparable metrics.
Risk & Volatility
HIFS is the less volatile stock with a 1.20 beta — it tends to amplify market swings less than LMND's 2.50 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PTRN currently trades 89.6% from its 52-week high vs PRCH's 58.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.65x | 2.15x | 1.20x | 2.50x |
| 52-Week HighHighest price in past year | $21.40 | $19.44 | $338.00 | $99.90 |
| 52-Week LowLowest price in past year | $8.92 | $6.36 | $220.76 | $35.70 |
| % of 52W HighCurrent price vs 52-week peak | +89.6% | +58.6% | +85.1% | +60.8% |
| RSI (14)Momentum oscillator 0–100 | 58.3 | 58.5 | 53.4 | 60.7 |
| Avg Volume (50D)Average daily shares traded | 1.2M | 1.8M | 35K | 1.5M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: PTRN as "Buy", PRCH as "Buy", LMND as "Buy". Consensus price targets imply 17.4% upside for PTRN (target: $23) vs -18.2% for PRCH (target: $9). HIFS is the only dividend payer here at 0.87% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | — | Buy |
| Price TargetConsensus 12-month target | $22.50 | $9.33 | — | $71.00 |
| # AnalystsCovering analysts | 6 | 13 | — | 15 |
| Dividend YieldAnnual dividend ÷ price | — | — | +0.9% | — |
| Dividend StreakConsecutive years of raises | — | 1 | 1 | — |
| Dividend / ShareAnnual DPS | — | — | $2.49 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | 0.0% |
HIFS leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). PRCH leads in 1 (Profitability & Efficiency). 2 tied.
PTRN vs PRCH vs HIFS vs LMND: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PTRN or PRCH or HIFS or LMND a better buy right now?
For growth investors, Lemonade, Inc.
(LMND) is the stronger pick with 40. 2% revenue growth year-over-year, versus 8. 9% for Hingham Institution for Savings (HIFS). Hingham Institution for Savings (HIFS) offers the better valuation at 11. 6x trailing P/E (20. 5x forward), making it the more compelling value choice. Analysts rate Pattern Group Inc. Series A Common Stock (PTRN) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PTRN or PRCH or HIFS or LMND?
On forward P/E, Hingham Institution for Savings is actually cheaper at 20.
5x.
03Which is the better long-term investment — PTRN or PRCH or HIFS or LMND?
Over the past 5 years, Pattern Group Inc.
Series A Common Stock (PTRN) delivered a total return of +22. 6%, compared to -37. 0% for Porch Group, Inc. (PRCH). Over 10 years, the gap is even starker: HIFS returned +151. 6% versus LMND's -12. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PTRN or PRCH or HIFS or LMND?
By beta (market sensitivity over 5 years), Hingham Institution for Savings (HIFS) is the lower-risk stock at 1.
20β versus Lemonade, Inc. 's 2. 50β — meaning LMND is approximately 109% more volatile than HIFS relative to the S&P 500. On balance sheet safety, Pattern Group Inc. Series A Common Stock (PTRN) carries a lower debt/equity ratio of 5% versus 18% for Porch Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — PTRN or PRCH or HIFS or LMND?
By revenue growth (latest reported year), Lemonade, Inc.
(LMND) is pulling ahead at 40. 2% versus 8. 9% for Hingham Institution for Savings (HIFS). On earnings-per-share growth, the picture is similar: Hingham Institution for Savings grew EPS 92. 7% year-over-year, compared to 19. 3% for Lemonade, Inc.. Over a 3-year CAGR, LMND leads at 42. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PTRN or PRCH or HIFS or LMND?
Hingham Institution for Savings (HIFS) is the more profitable company, earning 23.
0% net margin versus -22. 4% for Lemonade, Inc. — meaning it keeps 23. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HIFS leads at 30. 7% versus -21. 8% for LMND. At the gross margin level — before operating expenses — PRCH leads at 70. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PTRN or PRCH or HIFS or LMND more undervalued right now?
On forward earnings alone, Hingham Institution for Savings (HIFS) trades at 20.
5x forward P/E versus 34. 7x for Pattern Group Inc. Series A Common Stock — 14. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PTRN: 17. 4% to $22. 50.
08Which pays a better dividend — PTRN or PRCH or HIFS or LMND?
In this comparison, HIFS (0.
9% yield) pays a dividend. PTRN, PRCH, LMND do not pay a meaningful dividend and should not be held primarily for income.
09Is PTRN or PRCH or HIFS or LMND better for a retirement portfolio?
For long-horizon retirement investors, Hingham Institution for Savings (HIFS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
20), 0. 9% yield, +151. 6% 10Y return). Lemonade, Inc. (LMND) carries a higher beta of 2. 50 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HIFS: +151. 6%, LMND: -12. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PTRN and PRCH and HIFS and LMND?
These companies operate in different sectors (PTRN (Technology) and PRCH (Technology) and HIFS (Financial Services) and LMND (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: PTRN is a small-cap high-growth stock; PRCH is a small-cap quality compounder stock; HIFS is a small-cap deep-value stock; LMND is a small-cap high-growth stock. HIFS pays a dividend while PTRN, PRCH, LMND do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.